Table 2.
Main category | Examples |
---|---|
Rheumatoid arthritis | ▸ Rheumatoid* (eg, rheumatoid lung, rheumatoid disease) |
A diagnosis or sign of inflammatory arthritis | ▸ Polyarthritis ▸ Polyarthropathy ▸ Palindromic rheumatism ▸ Rheumatic arthritis ▸ Psoriatic or gouty arthropathy ▸ Arthritis or arthropathy linked to infection |
Rheumatoid factor test
|
▸ Latex test ▸ Heterophile ▸ IgA agglutination test ▸ Rose-Waaler test ▸ Rheumatoid factor level ▸ RAHA test |
Referral to rheumatology | ▸ Rheumatology disorder monitoring ▸ Rheumatology treatment change ▸ Rheumatology management plan given ▸ Under care of rheumatologist |
Synovitis | – |
DMARD prescription | ▸ Separate table given for drug names |
Other arthritis symptoms or diagnosis | ▸ Allergic arthritis ▸ Transient arthropathy ▸ Unspecified polyarthropathy ▸ Unspecified monoarthritis ▸ Other specified arthropathy ▸ Arthritis NOS |
Immune/inflammatory markers that are not specific to RA | ▸ Antinuclear factor ▸ Antimitochondrial autoantibody ▸ Antismooth muscle autoantibody ▸ Parietal cell autoantibodies ▸ Autoimmune profile ▸ Antiliver kidney microsomal antibody level ▸ Plasma C reactive protein ▸ Serum C reactive protein level |
Joint pain or swelling symptoms
|
▸ Knee pain ▸ Joint abnormal ▸ Joint swelling ▸ Reduced joint movement ▸ Joint movement painful ▸ Joint stiffness ▸ Inflammation in the joint ▸ Movement limitation ▸ Joint pain ▸ Joint effusion |
*Indicates a 'wildcard' character where any term beginning with the keyword stem would be accepted for the search.
Arthritis of the MCP is a distinguishing feature of rheumatoid arthritis.
DMARD, disease-modifying antirheumatic drug; IgA, immunoglobulin A; RA, rheumatoid arthritis; MCP joint, metacarpophalangeal joints.